Amlodipine and pregnancy
Pro Research Analysisby 
Searched over 200M research papers
Amlodipine and Pregnancy: Safety, Efficacy, and Outcomes
Safety of Amlodipine in Early Pregnancy
Amlodipine, a calcium channel blocker commonly used to treat hypertension, has been studied for its safety during early pregnancy. Research involving 231 women with chronic hypertension, including 48 who received amlodipine in the first trimester, found no significant increase in the risk of birth defects compared to those who took other antihypertensives or no antihypertensives at all. The odds ratios for birth defects were 0.74 and 0.89 when comparing the amlodipine group to other antihypertensive and no-antihypertensive groups, respectively, indicating no significant difference in the incidence of morphologic abnormalities among the groups .
Pharmacokinetics and Placental Passage
The pharmacokinetics of amlodipine during the peripartum period have been evaluated, showing that amlodipine does cross the placenta. In a study of 16 pregnant women treated with amlodipine, the drug was detected in cord blood at delivery, but concentrations in breast milk and infant plasma were undetectable at 24-48 hours postpartum. This suggests that while amlodipine crosses the placenta, it is not present in significant amounts in breast milk, indicating a low risk for breastfeeding infants .
Efficacy in Managing Hypertension During Pregnancy
A pilot clinical trial compared the efficacy and safety of amlodipine, furosemide, and aspirin in managing mild to moderate chronic hypertension during pregnancy. The study found no significant differences in maternal complications, pre-term births, mean birth weight, or the proportion of small for gestational age infants among the treatment groups. This suggests that amlodipine is as effective as other treatments for managing hypertension during pregnancy .
Amlodipine and Polycystic Ovarian Syndrome (PCOS)
Amlodipine has also been studied for its potential benefits in women with clomiphene-resistant PCOS. Research indicates that amlodipine can improve pre-ovulatory follicular blood flow, increase endometrial thickness, and enhance clinical pregnancy rates. Women treated with amlodipine showed a significant increase in ovarian blood flow and a higher rate of mature follicle development compared to those receiving a placebo Naito2015Xiao-Lon2015.
Combined Treatment with Magnesium Sulfate
In cases of gestational hypertension, combining amlodipine with magnesium sulfate has shown promising results. A study involving 100 patients found that this combination significantly reduced blood pressure and improved pregnancy outcomes, including lower incidences of postpartum hemorrhage, premature labor, and neonatal complications compared to magnesium sulfate alone .
Case Reports and Observational Studies
Case reports have provided additional insights into the use of amlodipine during pregnancy. One report described three hypertensive women treated with amlodipine during the first trimester, with outcomes ranging from healthy births to intellectual delays and fetal demise. However, these adverse outcomes were not directly attributed to amlodipine exposure . Another study reported a lack of efficacy in a pregnant woman with HELLP syndrome, where amlodipine alone was insufficient to control blood pressure, necessitating additional antihypertensive medications .
Teratogenicity Concerns
An animal study raised concerns about potential teratogenic effects of amlodipine, reporting the development of a teratoma in one of the treated groups. However, such findings in animal models do not necessarily translate to human outcomes and require further investigation .
Conclusion
Overall, current research suggests that amlodipine is generally safe for use during pregnancy, with no significant increase in birth defects or adverse neonatal outcomes. It effectively manages hypertension and may offer additional benefits for women with PCOS. However, its use should be carefully monitored, especially in complex cases like HELLP syndrome. Further large-scale studies are needed to confirm these findings and ensure the safety of amlodipine for both mothers and their infants.
Sources and full results
Most relevant research papers on this topic